Navigation Links
Catalyst mystery unlocked
Date:8/18/2008

Different keys are not supposed to fit the same lock, but in biological systems multiple versions of a catalyst all make a reaction go, according to a new study that explains the phenomenon.

Scheduled for online publication in PNAS Early Edition sometime after Aug. 18, the study challenges entrenched ideas about the workings of catalysts.

The study also suggests a method for designing new catalysts.

Catalysts are molecules that speed up chemical reactions without participating in them. Thousands of industrial and biological processes rely on catalysts. In the human body, enzymes catalyze almost every reaction.

"The Holy Grail of enzyme catalysis and the ultimate manifestation of understanding of this process is the ability to design enzymes," said senior author Arieh Warshel, professor of chemistry at USC College.

He listed drug production, environmental chemistry and bioremediation as areas that could be revolutionized by custom-designed enzymes.

In the PNAS study, Warshel described a computational model that both explains a key aspect of catalyst function and suggests a design strategy.

Since the early days of catalyst chemistry, scientists had championed the "lock and key" model, which held that a catalyst worked by exquisitely surrounding and matching the reacting system (the substrate).

Warshel's group has published several papers in support of an alternate theory based on electrical attraction. According to the group, a perfect physical fit between catalyst and substrate is not necessary.

"What really fits is the electrostatic interaction between the enzyme active site to the substrate charges at the so-called transition state, where the bonds are halfway to being broken," Warshel said.

If Warshel is correct, catalyst and substrate would be less like lock and key, and more like two magnets: As long the opposite poles could get close to
'/>"/>

Contact: Carl Marziali
marziali@usc.edu
213-740-4751
University of Southern California
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CATalyst Council Forms to Address Feline Health Care
2. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
3. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
4. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
5. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
6. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
7. CATalyst Summit Declared a Success: Its All About the Cat!
8. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
9. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
10. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
11. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Hastings and Hastings, a discount accident lawyer in Phoenix, Arizona, ... number of visitors to its new Phoenix personal injury website. ... as well as auto accident cases and slip & fall ... others. Having served the state of Arizona for over 30 ... when it comes to dedicated and focused personal injury legal ...
(Date:9/19/2014)... 2014 Boston Scientific Corp. has moved ... http://www.transvaginalmeshlawsuithelp.com/ ) that is scheduled to go to ... LLP reports. According to a Motion filed ... asserts that claims involving its Solyx pelvic mesh device ... Code, a section of which shields manufacturers from ...
(Date:9/19/2014)... 2014 (HealthDay News) -- Although there is mounting ... most middle-aged and older adults in the United ... according to new research. Less than one-quarter ... set by the Department of Health and Human ... essential for promoting health and fitness and staying ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Lipitor lawsuits ... caused some patients to develop Type 2 diabetes continue ... underway in U.S. District Court, District of South Carolina, ... issued on September 12, 2014, discovery is underway and ... report noted that Pfizer, Inc., the manufacturer of Lipitor, ...
(Date:9/19/2014)... In partnership with Raw Beauty NYC, OC healthcare ... project’s social media efforts. StudioPMG is honored to be a ... of beauty as it applies to disabled women. , ... Baer and Vanessa Silberman, who wanted to create a photo ... Dixon, Wendy Crawford, Susan Solman and Sabrina Cohen later joined ...
Breaking Medicine News(10 mins):Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 4Health News:Adults Over 45 Not Meeting U.S. Muscle Strengthening Guidelines, Study Says 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2
... ... Wins ,Wharton Business Plan Competition Michelson Grand Prize with ,Device that Helps Osteoporosis ... for Co-eds, , ... Philadelphia, PA (PRWEB) April 29, 2010 -- The Wharton School of ...
... new gene expression study in embryonic stem cells has uncovered ... than once thought but is also heavily regulated by the ... in the April 30th edition of Cell , a ... the transcription process that serves to regulate expression of as ...
... ... ... version of Greenpeace’s Cool IT Leaderboard (1) reveals how some global IT companies are leading ... energy use, while others seem unable to decide if IT climate solutions are a significant ...
... mutation impacts how the brain communicates with limbs, researcher says ... that causes a phenomenon known as mirror movements has been ... unable to move one side of their body without moving ... right hand, the same movement occurs unintentionally in the left ...
... ... , ... NJ (Vocus) -- Volkmann, a market leader in vacuum conveying, introduces its “No-Tip ... flow issues involved when transferring powders, granules, pellets, capsules, tablets and other bulk ...
... Mice, frogs, and E. coli are standard organisms ... in part to technical advances, the reduced costs of genome ... of organisms used for research has greatly expanded. Scientists ... might better address their specific research question. Eighteen diverse ...
Cached Medicine News:Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 3Health News:Embryonic stem cells reveal oncogene's secret growth formula 2Health News:IT Leaderboard Showcases Growing Divide Between Talk and Action on Developing Climate Solutions 2Health News:IT Leaderboard Showcases Growing Divide Between Talk and Action on Developing Climate Solutions 3Health News:IT Leaderboard Showcases Growing Divide Between Talk and Action on Developing Climate Solutions 4Health News:Scientists Find Cause of Involuntary Mirror Movements 2
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
(Date:9/19/2014)... -- Larry J. Merlo , President and CEO of ... the National Press Club in Washington, D.C. ... stop selling tobacco products and its leadership in driving the ... "Dramatic changes in our health care system pose enormous challenges ... said. "CVS Health has a truly unique combination of business ...
(Date:9/19/2014)... Sept. 19, 2014  Alere Inc. (NYSE: ... the following statement today in support of President ... "As the global leader in rapid diagnostics for ... national strategy to address the serious threat of antibiotic ... the Administration on initiatives to promote the development of ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2
... Ability of Adecatumumab to Prolong Disease Free Survival ... March 23 Micromet, Inc. (Nasdaq: ... novel, proprietary antibodies for the treatment of cancer, ... of a randomized, controlled phase 2 trial of ...
... announced today that,the fourth LNA-based drug has been ... with cancer have now been treated with the ... Pharma and Enzon,Pharmaceuticals. The U.S. Food and Drug ... (IND) application,for the use of the LNA-based Survivin ...
Cached Medicine Technology:Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 2Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 3Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 4Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 5Another LNA-based RNA Inhibitor Enters Clinical Trials 2Another LNA-based RNA Inhibitor Enters Clinical Trials 3
... The Laserex Ultra Q is the fundamental ... cavity optimizes energy delivery and provides 2855% less ... to 2.54.0 mJs in contemporary systems. This ... dramatically reduces the risk of IOL pitting. ...
... The Ultrasonix 500 is a high-end, mobile ... based architecture provides a tremendous amount of ... contrast and resolution. Ultrasonix imaging systems ... modes including B, B/M, Pulsed Doppler, Color ...
Protects the eye during or after surgery or trauma. Clear window dressing. Protects the eye allowing the patient to see....
Protects the eye during or after surgery or trauma. 8mm diameter, lint free keeps cornea moist. Protects retina from operating microscope light rays....
Medicine Products: